Pharmacotherapy in Acutely Anemic Jehovah's Witnesses: An Evidence-Based Review.

Sean M McConachieZinah AlmadrahiKrista A WahbySheila M Wilhelm

Published in: The Annals of pharmacotherapy (2018)

There are currently not enough data to make definitive recommendations on the use of pharmacological agents to treat severe anemia in the JW population. Further evidence utilizing EPO and HBOCs will be beneficial to guide therapy.

Keyphrases

electronic health record
chronic kidney disease
early onset
big data
clinical practice
smoking cessation
iron deficiency
locally advanced
stem cells
machine learning
radiation therapy
mesenchymal stem cells
deep learning
replacement therapy